Eprint already available on another site (E-prints, Working papers and Research blog)
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions 2023.01.12.523740
Tiane, Assia; Schepers, Melissa; Reijnders, Rick A. et al.
2023
 

Files


Full Text
2023.01.12.523740v1.full.pdf
Author preprint (1.27 MB)
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Abstract :
[en] Introduction In the progressive phase of multiple sclerosis (MS), the hampered differentiation capacity of oligodendrocyte precursor cells (OPCs) eventually results in remyelination failure. We have previously shown that DNA methylation of Id2/Id4 is highly involved in OPC differentiation and remyelination. In this study, we took an unbiased approach by determining genome-wide DNA methylation patterns within chronically demyelinated MS lesions and investigated how certain epigenetic signatures relate to OPC differentiation capacity.Methods We compared genome-wide DNA methylation and transcriptional profiles between chronically demyelinated MS lesions and matched normal-appearing white matter (NAWM), making use of post-mortem brain tissue (n=9/group). DNA methylation differences that inversely correlated with mRNA expression of their corresponding genes were validated for their cell-type specificity in laser-captured OPCs using pyrosequencing. The CRISPR-dCas9-DNMT3a/TET1 system was used to epigenetically edit human-iPSC-derived oligodendrocytes to assess the effect on cellular differentiation.Results Our data show hypermethylation of CpGs within genes that cluster in gene ontologies related to myelination and axon ensheathment. Cell type-specific validation indicates a region-dependent hypermethylation of MBP, encoding for myelin basic protein, in OPCs obtained from white matter lesions compared to NAWM-derived OPCs. By altering the DNA methylation state of specific CpGs within the promotor region of MBP, using epigenetic editing, we show that cellular differentiation can be bidirectionally manipulated using the CRISPR-dCas9-DNMT3a/TET1 system in vitro.Conclusion Our data indicate that OPCs within chronically demyelinated MS lesions acquire an inhibitory phenotype, which translates into hypermethylation of crucial myelination related genes. Altering the epigenetic status of MBP can restore the differentiation capacity of OPCs and possibly boost (re)myelination.Competing Interest StatementThe authors have declared no competing interest.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Tiane, Assia
Schepers, Melissa
Reijnders, Rick A.
Veggel, Lieve Van
Chenine, Sarah
Rombaut, Ben
Dempster, Emma
Verfaillie, Catherine
Wasner, Kobi
Grünewald, Anne  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Molecular and Functional Neurobiology
Prickaerts, Jos
Pishva, Ehsan
Hellings, Niels
Hove, Daniel Van Den
Vanmierlo, Tim
More authors (5 more) Less
Language :
English
Title :
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions 2023.01.12.523740
Publication date :
2023
Publisher :
Cold Spring Harbor Laboratory
Available on ORBilu :
since 02 June 2023

Statistics


Number of views
70 (3 by Unilu)
Number of downloads
60 (1 by Unilu)

Bibliography


Similar publications



Contact ORBilu